These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36220043)

  • 1. Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia.
    Obed MN; Toresani I; Mykietuk A; Nannini EC
    Medicina (B Aires); 2022; 82(5):794-797. PubMed ID: 36220043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.
    Singh KV; Tran TT; Nannini EC; Tam VH; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of safety and outcomes with cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bloodstream infections.
    Miller MA; Fish DN; Barber GR; Barron MA; Goolsby TA; Moine P; Mueller SW
    J Microbiol Immunol Infect; 2020 Apr; 53(2):321-327. PubMed ID: 30190234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care.
    Johnson TM; Molina KC; Miller MA; Kiser TH; Huang M; Mueller SW
    Int J Antimicrob Agents; 2021 Apr; 57(4):106310. PubMed ID: 33609718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli.
    Morrisette T; Lagnf AM; Alosaimy S; Rybak MJ
    Eur J Clin Microbiol Infect Dis; 2020 Nov; 39(11):2199-2203. PubMed ID: 32535805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus.
    Li J; Echevarria KL; Hughes DW; Cadena JA; Bowling JE; Lewis JS
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5117-24. PubMed ID: 24936596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.
    Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V
    Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Ulloa ER; Singh KV; Geriak M; Haddad F; Murray BE; Nizet V; Sakoulas G
    Clin Infect Dis; 2020 Sep; 71(6):1413-1418. PubMed ID: 31773134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
    Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
    Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Outcomes of Daptomycin Versus Anti-Staphylococcal Beta-Lactams in Definitive Treatment of Methicillin-susceptible Staphylococcus aureus Bloodstream Infections.
    Agnello S; Wardlow LC; Reed E; Smith JM; Coe K; Day SR
    Int J Antimicrob Agents; 2021 Aug; 58(2):106363. PubMed ID: 34033912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Geriak M; Haddad F; Rizvi K; Rose W; Kullar R; LaPlante K; Yu M; Vasina L; Ouellette K; Zervos M; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline as salvage therapy for complicated MRSA bacteremia: case series and analysis.
    Bhowmick T; Liu C; Imp B; Sharma R; Boruchoff SE
    Infection; 2019 Aug; 47(4):629-635. PubMed ID: 30955166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Nafcillin and Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia.
    Twilla JD; Algrim A; Adams EH; Samarin M; Cummings C; Finch CK
    Am J Med Sci; 2020 Jul; 360(1):35-41. PubMed ID: 32376001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
    Yetmar ZA; Khodadadi RB; Go JR; Chesdachai S; Abu Saleh OM
    Eur J Clin Microbiol Infect Dis; 2023 Apr; 42(4):423-430. PubMed ID: 36800065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
    Cheng MP; Lawandi A; Butler-Laporte G; De l'Étoile-Morel S; Paquette K; Lee TC
    Clin Infect Dis; 2021 May; 72(9):e196-e203. PubMed ID: 32667982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.
    Cheng MP; Lawandi A; Butler-Laporte G; Paquette K; Lee TC
    Trials; 2018 May; 19(1):297. PubMed ID: 29843781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.